Countries Australia
Resonance Health Joins Forces with Micron, Inc. for Strategic Entry into Japan's Healthcare Sector
Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...
March 28, 2024 | News
Alphamab Oncology Launches Groundbreaking Clinical Trial in Australia for Advanced Cancer Treatment
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed in Australia in the clinical study (JSKN033-101) of JSKN0...
March 26, 2024 | News
Australia Grants AUD 17M to TB Alliance for Innovative Treatments
The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Allia...
March 25, 2024 | News
Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,
Antengene Corporation Limited, a prominent global biopharmaceutical entity focused on the development and commercialization of pion...
March 21, 2024 | News
First Patient Treated in Phase 2 GvHD Trial
Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, c...
March 06, 2024 | News
Telix Pharmaceuticals Acquires ARTMS Inc. to Revolutionize Radioisotope Production
Telix Pharmaceuticals announced its acquisition of radioisotope production technology firm ARTMS Inc. ("ARTMS"), including its advanced cyclotron-based iso...
March 05, 2024 | News
Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC
In this insightful interview with BioPharma APAC, Ruth Kuguru, Executive Director of Communications & Engagement at Novartis for Asia Pacific, Middle E...
March 05, 2024 | Interaction
Innovent Begins Phase 1 Trial of IBI3002 in Australia
This FIH study (NCT06213844) is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) study to evaluate the safety, tolerabil...
March 01, 2024 | News
BioCina and NovaCina Join Forces for Integrated Biologics Solutions
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish...
February 28, 2024 | News
Australian Telix Boosts US Presence with IsoTherapeutics Acquisition
Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract m...
February 27, 2024 | News
Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics
Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...
February 26, 2024 | News
Cure Brain Cancer Foundation CEO Lance Kawaguchi Triumphs in SouthPoleTrek4Cancer, Raising Over $1 Million
Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...
February 26, 2024 | News
Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe
CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...
February 26, 2024 | News
AIRS Medical Partners with ParagonCare to Boost SwiftMR™ Sales in Australia and New Zealand
AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited&nbs...
February 19, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
